MTOR and pancreatic ductal adenocarcinoma: HnRNPA2B1 could act as a novel regulator of oncogenic K-ras, modulating PI3K/AKT/mTOR signal pathway in K-ras-dependent pancreatic ductal adenocarcinoma cells [41,42].